INTRODUCTION
The ectopic production of ACTH associated with a well-defined clinical variant of Cushing's syndrome has been described in patients with tumors of diverse tissue Rccived for puiblicationt 12 Septemtlber 1973 antd in revised form 15 November 1973. origin (See reference 1 for review). However, carcinoma of the lung has been the tumor most commonly associated with ectopic ACTH production (1) . Big ACTH, an immunoreactive form of ACTH that is considerably larger than the well characterized 39 amino acid polypeptide (little ACTH), has recently been described as the major component of ACTH in the plasma of two patients with ectopic ACTH production and Cushing's syndrome (2, 3) . Since big ACTH has only minimal in vitro biologic activity (4, 5) the possibility of demonstrating tumor production of immunoreactive ACTH, even in the absence of clinical Cushing's syndrome, was suggested (6) .
In this report we describe the incidence, concentration and immunologic forms of ACTH in tumor tissue (primarily carcinoma of the lung) from patients with and without Cushing's syndrome. The concentrations and immunologic forms of ACTH in the plasma of such patients is compared with those of patients with chronic obstructive pulmonary disease (COPD), other severe lung disease and a control group. Whether plasma ACTH may serve as a useful biologic marker for the presence of carcinoma of the lung is considered.
METHODS
Tissue extracts from human tumor, pituitary gland, and normal tissue were prepared from freshly frozen tissues obtained at surgery or at autopsy. Generally the time from death to autopsy was not known. To our knowledge careful studies on the rapidity with which pituitary or tumor hormone concentration declines after death have not been performed.
The tissues were sectioned while still frozen, minced, and homogenized for 1 min with a Teflon pestle at 4'C at a concentration of 0.1 g tissue/ml in either 20%o acetone: 1%o acetic acid, 8 M urea, or distilled water. The distilled water extract was then boiled for 3 min and immediately cooled. After centrifugation of all extracts at 3,000 rpm for 5 min at 4°C the sedimented cell debris was discarded, and porti&nis of the suipernatatnts were suhjected to radioimmunioassay.
Extracting vessels were meticulously cleaned between successive extractions by washing successively with solu-tions of detergent, acetone-acetic acid, and acetone. Normal tissue was then extracted to verify freedom from contamination. Since nonspecific lowering of the B/F ratio might falsely be attributed to apparent hormone concentration, tissue extracts were subjected to Sephadex gel filtration to assure that the bulk of the apparent hormonal material had filtration characteristics of big or little ACTH.
Plasma samples were generally obtained in the late afternoon to avoid the early morning peak in diurnal levels. Heparinized samples were drawn from in-hospital patients with a tissue diagnosis of carcinoma of the lung or with clinical diagnoses of chronic obstructive pulmonary disease or pulmonary tuberculosis. Most of the samples were obtained from patients at the East Orange or Bronx Veterans Administration Hospitals, although occasional samples were provided from other sources. Plasma samples from normal laboratory personnel and out-patients of our thyroid clinic with no known pertinent disease served as controls.
The immunoreactive ACTH content of tumor extracts and plasma samples was determined by radioimmunoassay with a sensitivity of 1-2 pg/ml incubation mixture according to methods previously described (3, 7) . It was considered desirable to verify the nature of the immunoreactive material by Sephadex gel filtration. To perform this study the minimal concentration in the tissue which could be detected was 2-4 ng immunoreactive ACTH per gram of tissue. The acetone-acetic acid extracts were also assayed for immunoreactive growth hormone (8) and parathyroid hormone (9) , and the boiled water extracts were assayed for immunoreactive gastrin (10) according to methods established in this laboratory.
To determine the relative fraction of big and little ACTH in tissue extracts and plasma samples, portions were subjected to gel filtration at 4°C on Sephadex G-50 fine columns, 1 cm X 50 cm. Volumes up to 3 ml were applied to the columns. The extracts were fortified with trace amounts of [...I]albumin, [5I]ACTH, and [I] Na, which served as markers, before being placed on the columns. The columns were eluted with 0.1 M NaCl containing 10% hormone-free plasma and 0.5%o 2-mercaptoethanol. Successive 1 ml fractions were collected and counted for radioactivity, and appropriate portions up to 1 ml were subjected to radioimmunoassay (3, 7) . The observed trailing of immunoreactive ACTH beyond the zone of elution of authentic big or little ACTH may arise 0~~~~~~~~. cinoma of the lung ranged from 5.0 ng/g wet tissue to 55.0 ng/g (Table III) . Similar concentrations were found in lymph node and liver metastases. From Table  III urea generally resulted in no significant differences in the total immunoreactive ACTH recovered or in the percentage of big ACTH present (Fig. 1) . The distribution of hormonal forms in six other lung carcinoma tissues extracted with two of the solvents is shown in Fig. 2 . In five out of six extracts the ACTH was almost exclusively big; in the sixth, patient Row., the two immunoreactive components were present in fairly equal amounts.
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In Fig. 3 In view of the ubiquitous presence of immunoreactive ACTH in primary and metastatic carcinoma of the lung, the concentrations of immunoreactive ACTH in the plasma of such patients was determined (Fig. 4) . 53% of 83 patients with carcinoma of the lung had ACTH concentrations in afternoon specimens greater than 150 pg/ml. Over 90% of the plasma specimens with values less than 150 pg/ml were obtained from patients with a history of radiation therapy or chemotherapy. Two of the untreated patients in this group had a tissue diagnosis of well-differentiated epidermoid carcinoma and are alive and in good clinical condition 2 yr after the initial diagnosis. Only 31% of 45 patients with chronic obstructive pulmonary disease, 28% of 25 patients with other severe lung disease, and 6% of 33 controls had these elevated values.
Fractionation of plasma containing elevated ACTH concentrations (Fig. 5) (45-90%). These patterns contrast sharply with those observed when plasma ACTH is elevated in response to pituitary stimulation ( In six patients with ectopic Cushing's syndrome, three of whom are shown in Fig. 6 , more than 90% of the plasma ACTH was in the big form.
Plasma ACTH does not necessarily reflect tumor ACTH. In a patient with an insulinoma and ectopic Cushing's syndrome only big ACTH was found in the plasma, and yet the tumor extract had a significant fraction as little ACTH (Fig. 7) contained 5 ng of ACTH per gram of wet tissue, which is comparable to that found in the lowest of the human lung carcinoma tissues; 90% of the immunoreactivity was in the big form (Fig. 8) .
Plasma cortisol concentrations were determined for 45 lung carcinoma patients with elevated plasma ACTH.
Of these, 39 had plasma cortisol levels less than 20 ug/ 100 ml, five had levels between 20 and 30 i.g/lOO ml, and one had a plasma level of 33 'g/100 ml.
DISCUSSION
The ubiquitous presence of immunoreactive ACTH in both the primary and metastatic tumors of patients with carcinoma of the lung without clinical evidence of ectopic Cushing's syndrome is quite remarkable. There was a much lower incidence of ACTH in other tumors and ACTH was not detectable in comparable normal tissues. Some reports had suggested that ectopic ACTH production by lung carcinomas was more common than generally accepted. Hauger-Klevene (12) found either elevated plasma ACTH, lack of diurnal rhythm, or failure to suppress plasma ACTH by dexamethasone in 8 of 26 patients with lung carcinoma. Only one of the eight had plasma corticoids at 4 p.m. in excess of 30 lAg/iOO ml, and six of the eight had values of 20 ,ug/100 ml or less. Knight and Besser (13) noted the presence of immunoreactive ACTH in tumors of various tissues from patients without clinical Cushing's syndrome as well as from patients with the syndrome. However, in their study (13) the ACTH content of normal tissue extracts was not reported, and, in the absence of appropriate controls, one must consider whether the ACTH detected could have been due to accidental contamination or other nonspecific effects. In their study there was not clear distinction between the tumor content of ACTH in most patients with ectopic Cushing's syndrome due to oat cell carcinoma of the bronchus and tumors from patients without the syndrome.
The presence of immunoreactive ACTH and the absence of immunoreactive growth hormone, parathyroid hormone, and gastrin in the same tumors poses an interesting question. What is unique in the nature of the ACTH synthetic system that results in the preferential ectopic production of this hormone in carcinoma of the lung? For instance, if the mechanism of ACTH production in these tumors relates to derepression of genes, why are the genes controlling the synthesis of ACTH affected and not those of other hormones? Beck and Burger (14) have reported that 7 of 18 carcinomas of the lung contained immunoreactive growth hormone and the concentrations they found were well within the limits of our assay. Nonetheless growth hormone was not detectable in any of the tumors in our series.
The finding of a higher fraction of the total immunoreactive ACTH in the big form in lung tumors as compared with a lower fraction in this form in the pituitary gland is not unexpected. It had earlier been shown (15) that in an islet-cell tumor the fraction of immunochemical insulin in the precursor form, proinsulin, is greater than that in normal pancreatic tissue of the same patient. The high fractional content of big ACTH is consistent with the hypothesis of a defect in the conversion of big to little ACTH. This defect may arise from (a) a qualitative or quantitative deficiency in an enzyme that facilitates the conversion of big ACTH to little ACTH, (b) a defect in the "packaging" of the enzyme together with the big ACTH which results in inhibition of enzymatic conversion, or (c) a factor in tumor tissue which acts as an inhibitor of enzymatic conversion. It is unlikely that preferential release of little ACTH is the mechanism responsible for the relative elevation of big ACTH in tumor tissue since big ACTH is also the predominant component in the circulation. Orth, Nicholson, Mitchell, Island, and Liddle have reported a high incidence of N-terminal and C-terminal ACTH fragments in tumors associated with ectopic Cushing's syndrome (16) . The antiserum used in our studies, as previously characterized (17) , is highly sensitive to the intact 1-39 ACTH, but is more than 20-fold less sensitive to the biologically active 1-24 N-terminal fragment and even less sensitive to the biologically inactive intermediate and C-terminal ACTH fragments.
It is therefore not surprising that immunoactive ACTH having an elution volume larger than that of the 1-39 peptide was not detected in our study. Furthermore Orth et al. (16) in their tumor extracts did not find an immunoactive ACTH corresponding to the big ACTH reported here. However their tumors were extracted and partially purified by cation-exchange chromatog- In patients with severe lung disease other than carcinoma of the lung or COPD, 28% had ACTH levels between 150 and 300 pg/ml. The distribution between little and big ACTH was not determined in these samples nor were the control procedures of dexamethasone suppression or multiple sampling used to evaluate whether the elevated levels were simply secondary to the stress of severe disease. It has been our experience that an infusion of 300 mg of hydrocortisone over a 3 h period rapidly returns metyrapone-stimulated ACTH levels to normal (7) 
